Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel

Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance.

Publication ,  Journal Article
Ando, S; Sarlis, NJ; Krishnan, J; Feng, X; Refetoff, S; Zhang, MQ; Oldfield, EH; Yen, PM
Published in: Mol Endocrinol
September 2001

Patients with TSH-secreting pituitary tumors (TSHomas) have high serum TSH levels despite elevated thyroid hormone levels. The mechanism for this defect in the negative regulation of TSH secretion is not known. We performed RT-PCR to detect mutations in TRbeta from a surgically resected TSHoma. Analyses of the RT-PCR products revealed a 135-bp deletion within the sixth exon that encodes the ligand-binding domain of TRbeta2. This deletion was caused by alternative splicing of TRbeta2 mRNA, as near-consensus splice sequences were found at the junction site and no deletion or mutations were detected in the tumoral genomic DNA. This TRbeta variant (TRbeta2spl) lacked thyroid hormone binding and had impaired T3-dependent negative regulation of both TSHbeta and glycoprotein hormone alpha-subunit genes in cotransfection studies. Furthermore, TRbeta2spl showed dominant negative activity against the wild-type TRbeta2. These findings strongly suggest that aberrant alternative splicing of TRbeta2 mRNA generated an abnormal TR protein that accounted for the defective negative regulation of TSH in the TSHoma. This is the first example of aberrant alternative splicing of a nuclear hormone receptor causing hormonal dysregulation. This novel posttranscriptional mechanism for generating abnormal receptors may occur in other hormone-resistant states or tumors in which no receptor mutation is detected in genomic DNA.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Mol Endocrinol

DOI

ISSN

0888-8809

Publication Date

September 2001

Volume

15

Issue

9

Start / End Page

1529 / 1538

Location

United States

Related Subject Headings

  • Two-Hybrid System Techniques
  • Triiodothyronine
  • Thyrotropin
  • Reverse Transcriptase Polymerase Chain Reaction
  • Recombinant Fusion Proteins
  • Receptors, Thyroid Hormone
  • Protein Isoforms
  • Pituitary Neoplasms
  • Humans
  • Genes, Reporter
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ando, S., Sarlis, N. J., Krishnan, J., Feng, X., Refetoff, S., Zhang, M. Q., … Yen, P. M. (2001). Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance. Mol Endocrinol, 15(9), 1529–1538. https://doi.org/10.1210/mend.15.9.0687
Ando, S., N. J. Sarlis, J. Krishnan, X. Feng, S. Refetoff, M. Q. Zhang, E. H. Oldfield, and P. M. Yen. “Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance.Mol Endocrinol 15, no. 9 (September 2001): 1529–38. https://doi.org/10.1210/mend.15.9.0687.
Ando S, Sarlis NJ, Krishnan J, Feng X, Refetoff S, Zhang MQ, et al. Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance. Mol Endocrinol. 2001 Sep;15(9):1529–38.
Ando, S., et al. “Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance.Mol Endocrinol, vol. 15, no. 9, Sept. 2001, pp. 1529–38. Pubmed, doi:10.1210/mend.15.9.0687.
Ando S, Sarlis NJ, Krishnan J, Feng X, Refetoff S, Zhang MQ, Oldfield EH, Yen PM. Aberrant alternative splicing of thyroid hormone receptor in a TSH-secreting pituitary tumor is a mechanism for hormone resistance. Mol Endocrinol. 2001 Sep;15(9):1529–1538.

Published In

Mol Endocrinol

DOI

ISSN

0888-8809

Publication Date

September 2001

Volume

15

Issue

9

Start / End Page

1529 / 1538

Location

United States

Related Subject Headings

  • Two-Hybrid System Techniques
  • Triiodothyronine
  • Thyrotropin
  • Reverse Transcriptase Polymerase Chain Reaction
  • Recombinant Fusion Proteins
  • Receptors, Thyroid Hormone
  • Protein Isoforms
  • Pituitary Neoplasms
  • Humans
  • Genes, Reporter